Trial intelligence / Profile preview

Propranolol and Stress-Induced DNA Damage

NCT03893617Phase 1Terminated

Start
Oct 2017
Primary completion
Jan 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in psychological stress comparing Propranolol group with Placebo group (2 arms). Primary endpoint: DNA Stress Response. Started Oct 2017; status: terminated.

02

Drugs

propranolol
03

Conditions

psychological stress

Beyond the preview

Go deeper on NCT03893617.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03893617.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call